Cargando…

Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study

OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Harita, Nobuko, Hayashi, Tomoshige, Sato, Kyoko Kogawa, Nakamura, Yoshiko, Yoneda, Takeshi, Endo, Ginji, Kambe, Hiroshi
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646021/
https://www.ncbi.nlm.nih.gov/pubmed/19074997
http://dx.doi.org/10.2337/dc08-1265
_version_ 1782164807767556096
author Harita, Nobuko
Hayashi, Tomoshige
Sato, Kyoko Kogawa
Nakamura, Yoshiko
Yoneda, Takeshi
Endo, Ginji
Kambe, Hiroshi
author_facet Harita, Nobuko
Hayashi, Tomoshige
Sato, Kyoko Kogawa
Nakamura, Yoshiko
Yoneda, Takeshi
Endo, Ginji
Kambe, Hiroshi
author_sort Harita, Nobuko
collection PubMed
description OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated with type 2 diabetes. RESEARCH DESIGN AND METHODS—The study participants were nondiabetic Japanese men (n = 8,570) aged 40–55 years at entry. Type 2 diabetes was diagnosed if fasting plasma glucose was ≥126 mg/dl or if participants were taking oral hypoglycemic medication or insulin. RESULTS—During the 4-year follow-up period, 877 men developed type 2 diabetes. Lower serum creatinine was associated with an increased risk of type 2 diabetes. The multiple-adjusted odds ratio for those who had serum creatinine levels between 0.40 and 0.60 mg/dl was 1.91 (95% CI 1.44–2.54) compared with those who had levels between 0.71 and 0.80 mg/dl. CONCLUSIONS—Lower serum creatinine increased the risk of type 2 diabetes.
format Text
id pubmed-2646021
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-26460212010-03-01 Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study Harita, Nobuko Hayashi, Tomoshige Sato, Kyoko Kogawa Nakamura, Yoshiko Yoneda, Takeshi Endo, Ginji Kambe, Hiroshi Diabetes Care Epidemiology/Health Services Research OBJECTIVE—Because skeletal muscle is one of the target tissues for insulin, skeletal muscle mass might be associated with type 2 diabetes. Serum creatinine is a possible surrogate marker of skeletal muscle mass. The purpose of this study was to determine whether serum creatinine level is associated with type 2 diabetes. RESEARCH DESIGN AND METHODS—The study participants were nondiabetic Japanese men (n = 8,570) aged 40–55 years at entry. Type 2 diabetes was diagnosed if fasting plasma glucose was ≥126 mg/dl or if participants were taking oral hypoglycemic medication or insulin. RESULTS—During the 4-year follow-up period, 877 men developed type 2 diabetes. Lower serum creatinine was associated with an increased risk of type 2 diabetes. The multiple-adjusted odds ratio for those who had serum creatinine levels between 0.40 and 0.60 mg/dl was 1.91 (95% CI 1.44–2.54) compared with those who had levels between 0.71 and 0.80 mg/dl. CONCLUSIONS—Lower serum creatinine increased the risk of type 2 diabetes. American Diabetes Association 2009-03 /pmc/articles/PMC2646021/ /pubmed/19074997 http://dx.doi.org/10.2337/dc08-1265 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Epidemiology/Health Services Research
Harita, Nobuko
Hayashi, Tomoshige
Sato, Kyoko Kogawa
Nakamura, Yoshiko
Yoneda, Takeshi
Endo, Ginji
Kambe, Hiroshi
Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title_full Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title_fullStr Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title_full_unstemmed Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title_short Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
title_sort lower serum creatinine is a new risk factor of type 2 diabetes: the kansai healthcare study
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646021/
https://www.ncbi.nlm.nih.gov/pubmed/19074997
http://dx.doi.org/10.2337/dc08-1265
work_keys_str_mv AT haritanobuko lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT hayashitomoshige lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT satokyokokogawa lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT nakamurayoshiko lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT yonedatakeshi lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT endoginji lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy
AT kambehiroshi lowerserumcreatinineisanewriskfactoroftype2diabetesthekansaihealthcarestudy